During the past decade, Enroll SpA conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Enroll SpA" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Enroll SpA" are "Systemic Lupus Erythematosus" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Enroll SpA" in a lesser frequency.

Most popular intervention types in "Enroll SpA" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Etrasimod" (3 trials), "Baricitinib" (2 trials), "Cenerimod 0.5 mg" (1 trials) and "Cenerimod 1 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Enroll SpA" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Enroll SpA". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Enroll SpA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Enroll SpA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".